Vikas Jaitak

4.0k total citations · 1 hit paper
95 papers, 3.1k citations indexed

About

Vikas Jaitak is a scholar working on Organic Chemistry, Molecular Biology and Food Science. According to data from OpenAlex, Vikas Jaitak has authored 95 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Organic Chemistry, 31 papers in Molecular Biology and 25 papers in Food Science. Recurrent topics in Vikas Jaitak's work include Synthesis and biological activity (26 papers), Essential Oils and Antimicrobial Activity (23 papers) and Computational Drug Discovery Methods (12 papers). Vikas Jaitak is often cited by papers focused on Synthesis and biological activity (26 papers), Essential Oils and Antimicrobial Activity (23 papers) and Computational Drug Discovery Methods (12 papers). Vikas Jaitak collaborates with scholars based in India, Austria and United States. Vikas Jaitak's co-authors include Ramit Singla, Amit Kumar, Kamalpreet Kaur, Yashika Bhalla, V. K. Kaul, V. K. Gupta, Avadh Biharee, Mayank Mayank, Manvendra Kumar and Vijay Kumar Kaul and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Phytochemistry.

In The Last Decade

Vikas Jaitak

91 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies

2015 403 citations Ramit Singla, Vikas Jaitak et al. European Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by Vikas Jaitak

Since Specialization

Citations

This map shows the geographic impact of Vikas Jaitak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Jaitak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Jaitak more than expected).

Fields of papers citing papers by Vikas Jaitak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas Jaitak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Jaitak. The network helps show where Vikas Jaitak may publish in the future.

Co-authorship network of co-authors of Vikas Jaitak

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas Jaitak. A scholar is included among the top collaborators of Vikas Jaitak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas Jaitak. Vikas Jaitak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic approach for triple-negative breast Cancer through poly (ADP-ribose) Polymerase-1 inhibitors: Current update 2025 ·Bioorganic Chemistry ·(unknown), Sudip Kumar Mandal, Swati Arya, Samir Kumar Samanta, Ashok Kumar, Mitali Panchpuri, Hassan Abdel‐Gawad, Vagish Dwibedi, Niranjan Das, Sankhadip Bose, Jeetendra Kumar Gupta, Vikas Jaitak, Santosh Kumar Rath	2
2	Recent advancements in plant metabolomics: trends, tools, and techniques 2025 ·Plant Biotechnology Reports ·(unknown), (unknown), Amit Kumar, Vikas Jaitak	1
3	Identification of phytochemicals from genus Potentilla as estrogen receptor-α inhibitors through molecular docking, molecular dynamic simulation and DFT calculations 2025 ·Journal of Biomolecular Structure and Dynamics ·Amit Kumar, (unknown), (unknown), (unknown), (unknown), (unknown), Sudip Chakraborty, Vinod Kumar, Vikas Jaitak	0
4	Recent Advancement in NMR Based Plant Metabolomics: Techniques, Tools, and Analytical Approaches 2024 ·Critical Reviews in Analytical Chemistry ·(unknown), Vikas Jaitak	9
5	Estrogen receptor alpha (ER-α) antagonistic activity of phytoconstituents from Potentilla atrosanguinea and Potentilla fulgens in breast cancer 2024 ·Fitoterapia ·(unknown), (unknown), (unknown), (unknown), Vinod Kumar, Monisha Dhiman, Vikas Jaitak	2
6	Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Amit Kumar, Vinod Kumar, Vikas Jaitak	12
7	Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies 2021 ·European Journal of Medicinal Chemistry ·(unknown), Kamalpreet Kaur, Vikas Jaitak	109
8	Engagement of phytoestrogens in breast cancer suppression: Structural classification and mechanistic approach 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Amit Kumar, Vikas Jaitak	48
9	Comprehensive temporal reprogramming ensures dynamicity of transcriptomic profile for adaptive response in Taxus contorta 2020 ·Molecular Genetics and Genomics ·Aasim Majeed, (unknown), Ram Kumar Sharma, Vikas Jaitak, Pankaj Bhardwaj	12
10	Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies 2020 ·Bioorganic & Medicinal Chemistry ·(unknown), Kamalpreet Kaur, Vikas Jaitak	101
11	Plant-Derived Natural Alkaloids as New Antimicrobial and Adjuvant Agents in Existing Antimicrobial Therapy 2019 ·Current Drug Targets ·(unknown), Vikas Jaitak	23
12	Gene and metabolite profiling reveals flowering and survival strategies in Himalayan Rhododendron arboreum 2018 ·Gene ·Shruti Choudhary, Sapna Thakur, Vikas Jaitak, Pankaj Bhardwaj	10
13	Biological Activity of Bunium persicum Essential Oil from Western Himalaya 2017 ·Planta Medica International Open ·Iris Stappen, Nurhayat Tabanca, Abbas Alı, David E. Wedge, Jürgen Wanner, Velizar Gochev, Vikas Jaitak, Brij Lal, Vijay Kumar Kaul, Erich Schmidt, Leopold Jirovetz	4
14	Synthesis of rebaudioside A from stevioside and their interaction model with hTAS2R4 bitter taste receptor 2016 ·Phytochemistry ·Ramit Singla, Vikas Jaitak	34
15	Interaction model of steviol glycosides from Stevia rebaudiana (Bertoni) with sweet taste receptors: A computational approach 2015 ·Phytochemistry ·Mayank Mayank, Vikas Jaitak	41
16	Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies breakdown → 2015 ·European Journal of Medicinal Chemistry ·(unknown), Ramit Singla, Vikas Jaitak	403
17	Invitro anti-mutagenic potential of potentilla fulgens: A western himalayan plant 2014 ·Journal of Natural Remedies ·(unknown), Rajbir Kaur, Vikas Jaitak	2
18	Essential Oils: New Perspectives in Human Health and Wellness 2014 ·Evidence-based Complementary and Alternative Medicine ·Fabio Firenzuoli, Vikas Jaitak, Györgyi Horváth, Imaël Henri Nestor Bassolé, William N. Setzer, Luigi Gori	35
19	Variability of volatile constituents inArtemisia maritimain western Himalaya 2008 ·Natural Product Research ·Vikas Jaitak, Bikram Singh, V. K. Kaul	18
20	Validated high-performance thin-layer chromatography method for steviol glycosides in Stevia rebaudiana 2008 ·Journal of Pharmaceutical and Biomedical Analysis ·Vikas Jaitak, A. Gupta, V. K. Kaul, Paramvir Singh Ahuja	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact